Increasing cases of neurological disorders, ongoing research activities, and private and government investments
The global nerve repair and regeneration market size is expected to reach USD 22.01 Billion in 2028 and register a revenue CAGR of 10.9% over the forecast period, according to a latest report by Reports & Data. A major factor driving market revenue growth is increasing cases of neurological disorders. According to World Health Organization (WHO), hundreds of millions of people are affected by neurological disorders worldwide. Alzheimer’s disease may contribute to 60–70% of cases and is regarded as the most common cause of dementia.
Increasing investments in research in the field of nerve repair and regeneration is resulting in the advent of additional opportunities for efficient neurological healthcare delivery. Ongoing research and development activities and private investments in the healthcare sector for advancements in surgery devices is expected to positively impact revenue growth of the market over the forecast period.
Moreover, market growth is projected to register an upward trend with the growing awareness about mental disorders among people. In addition, increasing cases of Central Nervous System (CNS) disorders and healthy lifestyle trends are some key factors expected to continue to fuel market growth going ahead.
However, high cost of nerve repair and regeneration devices and unfavorable government policies are some major factors restraining global nerve repair and regeneration market revenue growth over the forecast period.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1733
Some major players in the market research report include
AxoGen Inc., Baxter International Inc., Boston Scientific Corporation, Livanova PLC (Cyberonics Inc.), Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Integra Lifesciences Holding Corporation, Orthod Group Ltd., Polyganics B.V., Stryker Corporation, and Cyberonics Inc..
Increasing development of on-demand, digitally enabled, and seamlessly connected clinician-patient interactions to manage patient base is expected to drive pharma and healthcare market in the coming years. After the COVID-19 outbreak there has been a number of foundational shifts in the healthcare system. Some of the examples include increasing consumer involvement in health care decision-making, the rapid adoption of virtual health & other digital innovations, increasing focus on utilization of interoperable data & data analytics, and increased public-private collaborations in therapeutics and vaccine development. The increased public-private collaborations for vaccine development has arisen due to high pressure of regional governments. Health care providers, and other stakeholders have invested heavily to quickly pivot, adapt, and innovate therapeutics.
Surging demands and transition to patient-centric care delivery across geographies will change pharma and healthcare market trends through 2028.
The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and Machine Learning to enhance efficiency of medical products. Top companies in the market are focusing on R&D activities to expand their product offerings and cater to unmet medical needs.
This report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, and recent developments in both historic and present contexts.
Some Key Highlights From the Report:
On the basis of surgery type, the market report is segmented into direct neuropathy, nerve grafting, neuromodulation surgery, and stem cell therapy. Among these, the ransomware segment accounted for largest revenue share in 2020 due to rise in ransomware attacks by cyber criminals to encrypt a victim’s files. The attacker demands few hundred dollars to thousands to restore access to the data.
On the basis of product type, the market report is segmented into biomaterial, neuromodulation surgery devices, external, and internal. Among these, the neuromodulation surgery devices segment is expected to register a significantly rapid revenue CAGR during the forecast period due to the increasing neurological disorders such as epilepsy and peripheral nerve injuries.
Asia Pacific nerve repair and regeneration market is expected to register fastest revenue growth rate over the forecast period due to increasing population suffering from nerve related diseases in the emerging economics such as India and China where hospitalization requires at large extent.
Revenue from North America nerve repair and regeneration market is projected to account for a significantly larger revenue share and dominate other regional markets over the forecast period. This can be attributed to rapid technological advancements in the field of nerve repair and regeneration, and increasing cases of neurological disorders patients.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1733
Segments covered in the report:
For the purpose of this report, Reports & Data has segmented the global nerve repair and regeneration market on the basis of surgery type, product type and region:
Surgery Type Outlook (Revenue, USD Billion; 2018 – 2028)
Group Fascicular Repair
Stem Cell Therapy
Product Type Outlook (Revenue, USD Billion; 2018 – 2028)
Neuromodulation Surgery Devices
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Regional Outlook (Revenue, USD Billion; 2018 – 2028)
Middle East and Africa
The report segments the Nerve Repair and Regeneration market on the basis of product types, applications, end-use industries, and regions among others. The report offers insights into key factors influencing the revenue growth of the segment and provides information about lucrative investment opportunities to stakeholders, investors, and clients.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1733
Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized as per your requirements.
Read More Reports:-
Peripherally Inserted Central Catheters Market @ https://www.medgadget.com/2020/03/peripherally-inserted-central-catheters-market-to-reach-usd-1-22-billion-by-2027-vygon-s-a-medtronic-plc-becton-dickinson-and-company-cook-medical.html
Endometrial Resection Devices Market @ https://www.medgadget.com/2020/03/endometrial-resection-devices-market-to-reach-usd-1-54-billion-by-2027-minerva-surgical-cooper-surgical-rf-medical-medgyn-inc-biosense-webster.html
Vaginal Specula Market @ https://www.medgadget.com/2020/03/vaginal-specula-market-to-reach-usd-1-07-billion-by-2027-b-braun-melsungen-ag-teleflex-inc-integra-lifesciences-robinson-healthcare-dynarex-corp.html
Computed Tomography Imaging Market @ https://www.medgadget.com/2020/03/computed-tomography-imaging-market-to-reach-usd-9-13-billion-by-2027-canon-medical-systems-ge-healthcare-koning-corporation-fujifilm-holdings-corp.html
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]